347 related articles for article (PubMed ID: 10521444)
1. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.
Hu WH; Johnson H; Shu HB
J Biol Chem; 1999 Oct; 274(43):30603-10. PubMed ID: 10521444
[TBL] [Abstract][Full Text] [Related]
2. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
[TBL] [Abstract][Full Text] [Related]
3. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
Mühlenbeck F; Schneider P; Bodmer JL; Schwenzer R; Hauser A; Schubert G; Scheurich P; Moosmayer D; Tschopp J; Wajant H
J Biol Chem; 2000 Oct; 275(41):32208-13. PubMed ID: 10807904
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
Milani D; Zauli G; Rimondi E; Celeghini C; Marmiroli S; Narducci P; Capitani S; Secchiero P
J Neurochem; 2003 Jul; 86(1):126-35. PubMed ID: 12807432
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.
Natoli G; Costanzo A; Moretti F; Fulco M; Balsano C; Levrero M
J Biol Chem; 1997 Oct; 272(42):26079-82. PubMed ID: 9334169
[TBL] [Abstract][Full Text] [Related]
7. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.
Tran SE; Holmstrom TH; Ahonen M; Kahari VM; Eriksson JE
J Biol Chem; 2001 May; 276(19):16484-90. PubMed ID: 11278665
[TBL] [Abstract][Full Text] [Related]
8. The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor.
Reuther-Madrid JY; Kashatus D; Chen S; Li X; Westwick J; Davis RJ; Earp HS; Wang CY; Baldwin AS
Mol Cell Biol; 2002 Dec; 22(23):8175-83. PubMed ID: 12417721
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.
Watanabe T; Jono H; Han J; Lim DJ; Li JD
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3563-8. PubMed ID: 14993593
[TBL] [Abstract][Full Text] [Related]
10. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.
Liu ZG; Hsu H; Goeddel DV; Karin M
Cell; 1996 Nov; 87(3):565-76. PubMed ID: 8898208
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
12. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.
Harper N; Farrow SN; Kaptein A; Cohen GM; MacFarlane M
J Biol Chem; 2001 Sep; 276(37):34743-52. PubMed ID: 11461927
[TBL] [Abstract][Full Text] [Related]
14. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.
Akiba H; Nakano H; Nishinaka S; Shindo M; Kobata T; Atsuta M; Morimoto C; Ware CF; Malinin NL; Wallach D; Yagita H; Okumura K
J Biol Chem; 1998 May; 273(21):13353-8. PubMed ID: 9582383
[TBL] [Abstract][Full Text] [Related]
15. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
16. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
Darnay BG; Ni J; Moore PA; Aggarwal BB
J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
[TBL] [Abstract][Full Text] [Related]
17. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
18. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
Shuto T; Xu H; Wang B; Han J; Kai H; Gu XX; Murphy TF; Lim DJ; Li JD
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8774-9. PubMed ID: 11438700
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase.
Takeuchi J; Hirota K; Itoh T; Shinkura R; Kitada K; Yodoi J; Namba T; Fukuda K
Antioxid Redox Signal; 2000; 2(1):83-92. PubMed ID: 11232604
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
